Media

The ASCO-SITC Clinical Immuno-Oncology Symposium is a three-day meeting focused on clinical and translational research in immuno-oncology and the implications for clinical care. ​ https://immunosym.org/

Immunomic Therapeutics Senior Director of Corporate Development to Present at Precision Lung Cancer World R&D Summit Discussion of lysosomal targeting technology as applied in cancer immunotherapy October 26, 2018 07:30

Immunomic Therapeutics CEO to Present at NYC Oncology Investor Conference To Discuss UNITE Technology Application in Oncology October 23, 2018 07:00 AM Eastern Daylight Time   NEW YORK--(BUSINESS WIRE)--Immunomic Therapeutics,

Panel to Highlight Advanced Therapeutics for Oncology October 03, 2018 12:00 AM Eastern Daylight Time BASEL, Switzerland--(BUSINESS WIRE)--Tomorrow, William Hearl, Ph.D., Chief Executive Officer (CEO) of Immunomic Therapeutics, Inc., will

Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company presented at the 2018 BIO Investor Forum held in San Francisco, CA on October 17-18. William Hearl, Ph.D., Immunomic’s Founder

 Immunomic Therapeutics, Inc. Founder and CEO Bill Hearl Joins Rich Bendis for BioTalk Click to hear the interview: Bill Hearl Q&A Dr. Bill Hearl is the Founder and Chief Executive Officer

Our very own Dr. Heiland has been featured on BioBuzz.  Click below to read the full Q&A Interview, as Dr. Heiland discusses our technology platform name change to UNITE and

ITI Founder & CEO will discuss new developments in cancer immunotherapy October 01, 2018 05:02 PM Eastern Daylight Time ROCKVILLE, Md. (BUSINESSWIRE)--Bill Hearl, Ph.D., Founder and Chief Executive Officer (CEO)

Please read the article authored by ITI titled, “The Use and Misuse of Cancer Life Expectancy Statistics” which explores how GBM patients adjust and deal with dire life expectancy statistics.

23rd ANNUAL SCIENTIFIC MEETING AND EDUCATION DAY OF THE SOCIETY FOR NEURO-ONCOLOGY Marriott Hotel, New Orleans, Louisiana Thursday, November 15, 8:00am - Sunday, November 18, 1:00pm Click here to view the preliminary

The 24th annual BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry. Delegates from all parts of the biotechnology value chain come to BIO-Europe to quickly identify, engage

The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables